Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Prepaid Assets of $512117.8 for Q4 2025, up 271.99% year-over-year from $137668.3 in Q4 2024, and down 90.89% quarter-over-quarter from $5.6 million in Q2 2025.
Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $512117.8 for Q4 2025.
- In Q4 2025, Prepaid Assets rose 271.99% year-over-year to $512117.8; the TTM figure through Dec 2025 stood at $512117.8 (up 271.99% YoY), while the FY2025 annual figure was $5.6 million, up 261.9% from the prior year.
- Prepaid Assets for Q4 2025 stood at $512117.8, down from $5.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $5.6 million in Q2 2025, with the low at $23563.0 in Q2 2024.
- The 5-year median for Prepaid Assets is $682299.8 (2021), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 97.74% in 2023, then surged 23749.94% in 2025.
- Alterity Therapeutics' Prepaid Assets stood at $1.2 million in 2021, then plunged by 55.32% to $520809.4 in 2022, then jumped by 361.03% to $2.4 million in 2023, then slumped by 94.27% to $137668.3 in 2024, then jumped by 271.99% to $512117.8 in 2025.
- Business Quant data shows ATHE's Prepaid Assets at $512117.8 in Q4 2025, $5.6 million in Q2 2025, and $137668.3 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 512,117.76 |
| Jun 30, 2025 | 5.62 Mn |
| Dec 31, 2024 | 137,668.33 |
| Jun 30, 2024 | 23,563.00 |
| Dec 31, 2023 | 2.40 Mn |
| Jun 30, 2023 | 26,092.86 |
| Dec 31, 2022 | 520,809.36 |
| Jun 30, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Jun 30, 2021 | 843,790.23 |
| Dec 31, 2020 | 254,870.38 |
| Jun 30, 2020 | 378,922.26 |
| Dec 31, 2019 | 211,606.15 |
| Jun 30, 2019 | 442,536.67 |
| Dec 31, 2018 | 80.85 |
| Jun 30, 2018 | 201,844.97 |
| Dec 31, 2017 | 300,146.52 |
| Jun 30, 2017 | 247.60 |
| Dec 31, 2016 | 107,128.62 |
| Jun 30, 2016 | 206.46 |